Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 26, 1996

View Archived Issues

New antihypertensive agent from Calpis Food Industry

Cyclic hexapeptide antifungal agents claimed by Lilly

Asta Medica reports new PDE IV and PDE V inhibitors

New NMDA antagonists described by Zeneca

New retinoid-like compounds from BMS

Melatonin receptor ligands described by ADIR

Cozaar introduced in U.K.

NABI to reformulate StaphVAX

New market introduction for valsartan

Somatogen reports plans for Optro

New market introduction for proton pump inhibitor

Anti-HIV drug now available in U.K.

VIMRx and Innovir to combine operations

Novel antipsychotic drug now available in U.K.

Rx for Sjogren's syndrome symptoms nearing launch

Cambridge NeuroScience/Allergan ophthalmic disease collaboration

Tularik receives patent coverage relating to drug discovery efforts

Worldwide rights offered for protein inducing oligodendroglia mitosis

New treatment for S. pneumoniae infection available for licensing

Children's Hospital of Philadelphia offers treatment of H. influenzae for licensing

Cationic antimicrobial peptides available for licensing

Purified or recombinant protein for HIV infection and cancer offered for licensing

Purified or recombinant proteins for HIV infection available for licensing

Vaccine against H. influenzae offered for licensing

Human brain-derived protein kinase offered for licensing

Uropontin and MAbs with potential in osteoporosis available for licensing

Diagnostic kit for cystic fibrosis offered for licensing

New use claimed for olanzapine

Lilly claims new indication for olanzapine

Neuregulin polypeptides described for treating retinal disorders

Lilly claims 5-HT7 antagonist for GI indications

HMG-CoA reductase inhibitors for preventing second heart attack

Nippon Shinyaku R&D pipeline in review

Protegrin development candidate selected by IntraBiotics

Gel for dermal augmentation introduced in Europe

OraVax and Pasteur-Merieux Connaught license H. pylori genome sequence

Creative BioMolecules/Stryker dental and periodontal collaboration

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...